Clinical Trial Update: Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy [Phase 2, Phase 3]

View source ↗

Summary

Results from Phase 2 and Phase 3 studies evaluating intravenous immunoglobulin therapy for Autoimmune Autonomic Ganglionopathy have been posted. The trial statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Autonomic Ganglionopathy

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Autoimmune Autonomic Ganglionopathy (AAG) | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-07-02